Management announcement 

Basel, Switzerland, October 22, 2012 

Syngenta today announced that Sandro Aruffo, Head of R&D, will take medical leave. During his absence, Robert Berendes, Head of Business Development, will assume ad interim leadership of the R&D function in addition to his existing responsibilities.

PDF version

Syngenta is one of the world's leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

 

Back to top

Brand Image

Media contacts:

 

Paul Barrett
Switzerland      +41 61 323 2323

 

Analyst/Investor contacts:

 

Jennifer Gough
Switzerland       +41 61 323 5059
USA                 +1 202 737 6521